Lecture 26 Flashcards
Why modify VSM in heart failure?(2)
reduce preload (partially) reduce afterload (completely)
why modify VSM in hypertension?
prevent consequences (ie retinal detachment)
why modify VSM in chronic renal failure?
restore glomerular filtration
Factors that affect SV
MAP=COxTPR(TPR is afterload)
CO=HRxSV
SV is contractility and EDV-ESV(ESV is afterload)
EDV is preload and venous return
What makes VSM contract?
macro(2) and micro(3) control
Macro- *Sympathethic NS and RAAS Micro- *sheer stress *pH, lactate, pO2 *endothelin
SNS—-
alpha-contraction
beta-relaxation
How does VSM contract at alpha receptor(4 steps)
NA binding->IP3 and DAG inc->inc intracelluar Ca->contraction
How does VSM relax at beta receptor
NA binding->inc adenyl cyclase->inc cAMP->inactive MLCK->relaxation
VOCC found in (3)
VSM
cardiac cells
nerves
L-type VO Ca channels found in (2)
VSM
Cardiac muscle-nodal tissue
Nitrates what type of drugs mechanism of action used in what do they do bioavailability
venodilator drug -NO doNOrs inc NO->cGMP->vasodiation -used in acute decompensated heart failure reduce preload -low bioavailability (1st pass effect)
Arteriodilator drugs- hydralazine mechanism what does it do(3) side effects(2)
mechanism unknown -drop arterial pressure quickly -reduce afterload -dec pulmonary edema side effects- hypotension (always use with diuretic) and reflex tachycardia
Ca channel blockers
what type of drug
mechanism of action
which channels are more targeted
arterial dilator
block L type Ca channels (heart and VSM)
bind to receptors in the active state and delay recovery to resting state
bind to Ca channel from the inside
more active channels more targeted(use dependence)
Ca channel blockers(arterial dilator) effects on HR
SA pacemaker activity and AV conduction slowed->dec HR
Ca channel blockers(arterial dilator) effect on myocardium
dec entry of Ca into the cell-> dec force of contraction
Ca channel blockers(arterial dilator) effect on vascular vessels
prevent rise in intracellular Ca needed for the formation of MLCK so ->relaxation(dilation of systemic arteries and arterioles)
alpha blockers
what type of drug
mechanism of action
what do they do
indirect vasodilator drug (arterial dilator)
- block alpha receptors on VSM->arterial dilation->dec TPR and BP
- Less NA binding->dec IP3 and DAG->dec intracellular Ca->relaxation
Beta blockers what type of drug Cardiac effect- Renal effect- Side effects-(3)
- indirect vasodilator (arterial dilator)
- dec HR (SA node), dec contractility (SV) therefore dec CO (dec arterial pressure)
- block B1 receptors on JG cells-> dec renin release and dec angiotensin formation (dec preload/blood volume) therefore dec TPR and dec MAP
- cold extremities, fatigue (dec CO), bronchoconstriction (asthma)
Chronic activation of RAAS
-persistent vasoconstriction->
inc blood volume ->
inc angiotensin ->
inc preload and afterload
inc preload
dec baroreceptor sensitivity
Drugs affecting RAAS (2)
ACE inhibitor
Angiotensin 2 receptor antagonists
drugs affecting RAAS- angiotensin 2 receptor antagonists(2)
more selective that ACE inhibitors
more complete inhibition of angiotensin
drugs affecting RAAS-ACE inhibitor
- dec vasoconstriction
- inhibit aldosterone release (dec Blood vol)
- reduce afterload (TPR)
- reduce preload (blood volume)
- MUST TEST RENAL FUNCTION FIRST